Literature DB >> 11562539

Immune and artificial selection in the haemagglutinin (H) glycoprotein of measles virus.

Christopher H Woelk1, Li Jin2, Edward C Holmes1, David W G Brown2.   

Abstract

We present a maximum likelihood (ML) analysis of the selection pressures that have shaped the evolution of the large (L) protein and the haemagglutinin (H) glycoprotein of measles virus (MV). A number of amino acid sites that have potentially been subject to adaptive evolution were identified in the H protein using sequences from every known genotype of MV. All but one of these putative positively selected sites reside within the ectodomain of the H protein, where they often show an association with positions of potential B-cell epitopes and sites known to interact with the CD46 receptor. This suggests that MV may be under pressure from the immune system, albeit relatively weakly, to alter sites within epitopes and hence evade the humoral immune response. The positive selection identified at amino acid 546 was shown to correlate with the passage history of MV isolates in Vero cells. We reveal that Vero cell passaging has the potential to introduce an artificial signal of adaptive evolution through selection for changes that increase affinity for the CD46 receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11562539     DOI: 10.1099/0022-1317-82-10-2463

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  A coalescent-based method for detecting and estimating recombination from gene sequences.

Authors:  Gil McVean; Philip Awadalla; Paul Fearnhead
Journal:  Genetics       Date:  2002-03       Impact factor: 4.562

2.  Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently.

Authors:  Maino Tahara; Makoto Takeda; Fumio Seki; Takao Hashiguchi; Yusuke Yanagi
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

3.  Antigenic Drift Defines a New D4 Subgenotype of Measles Virus.

Authors:  Miguel Ángel Muñoz-Alía; Claude P Muller; Stephen J Russell
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

4.  Characterization of measles virus strains causing SSPE: a study of 11 cases.

Authors:  L Jin; S Beard; R Hunjan; D W G Brown; E Miller
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

5.  Determination of spontaneous mutation frequencies in measles virus under nonselective conditions.

Authors:  Xiaomeng Zhang; Linda J Rennick; W Paul Duprex; Bert K Rima
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

6.  Pathogen evolution and disease emergence in carnivores.

Authors:  Alex J McCarthy; Marie-Anne Shaw; Simon J Goodman
Journal:  Proc Biol Sci       Date:  2007-12-22       Impact factor: 5.349

7.  The evolutionary and epidemiological dynamics of the paramyxoviridae.

Authors:  Laura W Pomeroy; Ottar N Bjørnstad; Edward C Holmes
Journal:  J Mol Evol       Date:  2008-01-24       Impact factor: 2.395

8.  Purifying selection can obscure the ancient age of viral lineages.

Authors:  Joel O Wertheim; Sergei L Kosakovsky Pond
Journal:  Mol Biol Evol       Date:  2011-06-24       Impact factor: 16.240

9.  Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodies.

Authors:  Patrycja J Lech; Gregory J Tobin; Ruth Bushnell; Emily Gutschenritter; Linh D Pham; Rebecca Nace; Els Verhoeyen; François-Loïc Cosset; Claude P Muller; Stephen J Russell; Peter L Nara
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

10.  Molecular evolution of hemagglutinin (H) gene in measles virus genotypes D3, D5, D9, and H1.

Authors:  Mika Saitoh; Makoto Takeda; Koichi Gotoh; Fumihiko Takeuchi; Tsuyoshi Sekizuka; Makoto Kuroda; Katsumi Mizuta; Akihide Ryo; Ryota Tanaka; Haruyuki Ishii; Hayato Takada; Kunihisa Kozawa; Ayako Yoshida; Masahiro Noda; Nobuhiko Okabe; Hirokazu Kimura
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.